Trinity compound research profile
Dermorphin
Dermorphin is a small chain of 7 amino acids that was discovered in the skin of South American tree frogs (Phyllomedusa species). It's made naturally by...
Research overview
Dermorphin is a small chain of 7 amino acids that was discovered in the skin of South American tree frogs (Phyllomedusa species). It's made naturally by these frogs as a defense chemical. Despite being filed under 'Cognitive/Neurological' in some lists, it's really not a brain-boosting peptide at all — it's an extremely powerful opioid painkiller, similar in effect to morphine but far stronger (prodermorphin processing).
Mechanism under study
Imagine your body has 'pain volume knobs' called opioid receptors. Dermorphin grabs onto one particular type of these knobs (called mu-opioid receptors) extremely tightly and turns the pain volume way down — even more effectively than morphine, gram for gram (Erspamer/Melchiorri, Br J Pharmacol 1981). It works through the exact same basic system that drugs like morphine, oxycodone, and heroin use, which is why it carries the same kinds of risks as those drugs.
Human evidence summary
There is no modern controlled human clinical trial program for dermorphin. Some limited historical human exposure has been documented in a review discussing why its drug development was abandoned (J Pain Res 2018), but this isn't the same as a proper clinical trial proving safety or effectiveness in people today.
Preclinical evidence summary
In animal models, dermorphin has been shown to be an extremely strong painkiller — far more potent than morphine on a dose-for-dose basis (Br J Pharmacol 1981). Scientists have also used dermorphin-like molecules as lab tools to study different sub-types of opioid receptors in animals (PNAS 1992).
Source material
Use the linked publications and records to evaluate study design, population, limitations, and relevance.